Increasing rates of healthcare utilization and improving hygiene standards driving demand for Medical and Surgical Gloves in emerging markets

Increasing rates of healthcare utilization and improving hygiene standards are driving demand for Medical and Surgical Gloves surging in emerging markets.

This newly updated analysis of the World Market for Disposable Medical Gloves from Marketstrat projects a decline in latex, the traditional leader, to about 40% over the next few years. Synthetics will preside with a 3% lead in cumulative growth rate. By the end of 2019, disposable medical gloves will exceed $5 billion in revenues on a global level. The US and EU collectively account for well over 60% of exam and surgical gloves used globally. Emerging markets will grow with about a 14% lead over the forecast period.

Asian manufacturers are ramping up nitrile production and investing in technology that allows them to alter the latex-nitrile balance to meet fluctuations in demand. A manufacturing shift that is tilted heavily toward nitrile appears to be essential for profitability. While the dominant trend in mature medical glove markets is diminishing use of latex, particularly powdered latex, emerging markets have a wide open door, with opportunities for all types of medical gloves. Hartalega and Supermax, two of the largest manufacturers and OEM suppliers are launching affordable OBM products to stake out new territory in emerging markets where competition from established MNC brands is relatively low.

The surgical glove segment in the US and EU regions is seeing a rapid expansion of high-tech synthetics like isoprene. Entry barriers continue to be high within this segment due to complexity of manufacturing surgical grade glove materials that can meet international standards. Most traditional glove manufacturers currently lack this capability and face new competition from manufacturers of synthetic polymers like Synthomer and Kraton Polymers.

Marketstrat’s report discusses these and other trends sculpting the medical glove landscape including market shares of leaders and competitive strategies. Market projections in revenues, ASPs and unit sales are provided for the 2013 to 2019 period.

Read More

World Market for Personal Mobility Devices (Wheelchairs, Scooters, Walking Aids)

The World Market for Mobility Devices is expected to grow at 3.8% CAGR to approach nearly $6 billion by 2018.

Key Segments:

  • Manual wheelchairs account for a larger share of revenues and unit sales than power wheelchairs or scooters.
  • The US and W. European market account for about 70 % of the world market.
  • The fastest growing segment is walking aids which includes canes and crutches, walkers and rollators.

Key Drivers

  • Growing patient population, primarily attributable to increasing longevity and rates of chronic diseases leading to impaired mobility.
  • Trend towards more active and independent living within the patient community.
  • Availability of compact, portable technologies that are partly or fully reimbursed through insurance.

The 2010 US Census determined that there were 3.6 million users of wheelchairs and a further 7 million users of canes, crutches or walkers.  Manual wheelchairs account for the largest share of the personal mobility devices market worldwide, since most wheelchair users have upper limb function.   Read More

World Infusion Pumps Market Projected to Touch $7.8 billion by 2018

The world Infusion Pumps Market is projected to reach over $7.6 billion by 2018.  The most commonly used drug infusion pumps are seen in healthcare facilities; these range from large, volumetric pumps, ambulatory pumps, syringe pumps and enteral feeding pumps.  Many compact portable models are also available for homecare and alternate care use.  Individual-use, pumps that allow more independent and active lifestyles, include the wearable insulin pumps and implantable pumps

Maketstrat’s report on the worldwide market for Infusion Pumps discusses how growth in this market is shaped by trends in regulatory requirements, technology, clinical use, geographical variations and demographic factors, etc.  Some of the issues highlighted in this report include:

  • Pump and administration set recalls, mandatory withdrawals and more stringent testing have impacted revenues from many well established brands and models of infusion pumps over the last few years.   The US market has been the hardest hit.
  •  The recent revenue impact while significant for certain product segments like volumetric and ambulatory pumps, is overshadowed by rising demand worldwide.
  • Volumetric pumps account for the largest share of revenues, while ambulatory pumps lead in unit sales.
  • In mature markets, sales of administration sets and other accessories is an important source of recurring revenue.
  • Highest overall growth is projected in the emerging markets of Asia and Latin America.
  • The insulin patch pump segment is currently the most dynamic in terms of innovation
  • Implantable pump segment is severely impacted in the short-term due to pump malfunction and recalls.
  • Syringe pumps will retain their foothold in all regional markets, and will be one of the highest growth segments on a global level.

Read More

World market for Endoscopic Visualization Devices expected to grow at more than 8% CAGR, driven by R&D, electronic medical records and integrated medical information systems

The world market for endoscopic visualization devices is expected to grow at more than 8% CAGR over the next seven years to over $5.7 billion by 2018.  The market is characterized by endoscopy and medical device giants like Olympus and Stryker that offer a broad spectrum of visualization devices from camera heads to printers, audio-visual giants like Sony and a number of niche players.

Manufacturers are focusing R & D efforts on application, ergonomics, latest information technology devices, workflow and cost-efficiency.  This in turn is helping to sustain a vibrant market for visualization devices. End-users are vying to acquire the latest scopes, HD cameras and flat-panel LCD monitors for their superior visualization capability for both diagnostic and surgical procedures.

Expanding use of electronic medical records and integrated medical information systems in established medical markets, calls for premium devices.  The latest endoscopy systems come with software that allows real-time image analysis and storage, e.g. Pentax’s EndoPRO iQ software suite with their HD Motion Picture Studio (HD MPS) allows image-inset in electronic reports. It can also store and catalog video segments for rapid keyword searches.

Read More

Small Joints & Extremities Reconstruction (Arthroplasty) Devices Market Growing Faster Than the Hip and Knee Replacement Market

The small joint and extremities reconstruction market is growing faster than the hip and knee replacement market.  New advanced technologies will help this specialty market grow at a CAGR of about 9 percent over the next few years.  Compared to replacement of large joints, small joint reconstruction is a far less common procedure, although the devices have been around for the last few decades.  A steady stream of innovations, many developed by the surgeons themselves, underscores the urgent need to meet growing patient demand.

For  detailed information on this research, please click this Marketstrat link.

The US and Europe account for the predominant share of the small joints replacement market.  Emerging healthcare markets are currently focused on large joint replacements, although small joint procedures will soon catch up.


Key trends and characteristics in this market include:

  • Joint diseases will continue being the leading cause of disability in older people.    Growth of this patient base is accelerating as populations around the world age, and rates of chronic inflammatory diseases, osteoarthritis and obesity soar.
  • Despite the high complication rate, clinical studies from all over the world show that arthroplasty can be used to successfully treat degenerative diseases and repetitive motion injuries caused by sports and occupational tasks.
  • Patient demands are also changing with increasing life expectancy.  People with end-stage arthritis are looking for treatment alternatives to arthrodesis that restore mobility and offer a greater quality of life.
  • Shoulder replacement or arthroplasty devices are the most common type of small joint replacements, accounting for almost three quarters of the $917million market in 2011.
  • Elbow and ankle replacements offer high growth potential due to high rates of injury.  There are only a handful of ankle replacement devices leaving a wide open field for new entrants.
  • Extremities reconstruction, namely digits, comprises the smallest segment of this market, due in large part to procedural complexity.
  • The severe shortage of trained surgeons is a major restraint needing to be addressed.
  • More successful technologies are critical in clearing regulatory hurdles, improving reimbursement, and patient acceptance.
  • The market is dominated by well-established joint reconstruction specialists such as DePuy, Tornier, Zimmer and Biomet, closely followed by other orthopedic giants like Stryker, Smith and Nephew and Wright Medical.   These companies compete fiercely for high-end products with highly reputed niche players such as Integra Life Sciences and Small Bone Innovations. Read More

Opportunities and Challenges in the US Market for Orthopedic Braces and Supports

More than 5 million knee braces and supports were sold in the US in 2011, many of them for sports injuries of the knee.  Other commonly used orthopedic bracing devices are for the ankle and wrist. Orthopedic braces and supports offer protection to joints, tendons and ligaments as well as providing pain relief and increased mobility for people suffering from a wide range of musculoskeletal problems.  The total US market for bracing devices used for the knee, ankle, wrist, shoulder and back is expected to grow at almost 5 percent CAGR over the next few years.

According to Marketstrat Inc. the US Market for Orthopedic Braces and Supports is characterized by some well-established segments and others that are under-penetrated and have good growth potential.  The report highlights the following key trends and characteristics of the braces and supports market:

 

  • Segments that are well established and have good insurance coverage include knee braces for osteoarthritis and post-op and rehabilitative braces for all joints that are prescribed by a clinician.
  • Knee bracing accounts for the largest share of revenues.  The US market for knee braces and supports is expected to exceed $1.2 billion in revenues by 2018.
  • Good growth opportunities exist in the ankle and wrist braces and supports market due to high injury rates.  The ankle segment in particular has good growth potential.
  • Consumers are willing to pay out-of-pocket for many products; off-the-shelf soft braces and supports for pain relief and protection offer good alternatives to prescription products.  With looming reimbursement restrictions, off-the-shelf products and easily-customized devices offer lucrative opportunities for manufacturers to expand their market share.

Read More

Opportunities and Challenges in the world Hip and Knee Implants Market

Marketstrat’s new research “Orthopedic Reconstruction Devices (Hip & Knee Implants) Markets Worldwide.” shows that the world knee and hip reconstruction market is about $14 billion in 2011, and expected to grow at a CAGR of 4.7 percent upto 2016.  The market is characterized by a wide range of options, price variation and the elective nature of the procedure makes it particularly sensitive to economic trends. More 75 percent of the market is accounted for by developed economies; however highest growth rates are in emerging markets particularly China and India.  The largest product segments are cemented knee and hip implants.

Factors driving the market inclue burgeoning rates of age-related conditions like osteoarthritis and osteoporosis, obesity-related conditions like diabetes that lead to peripheral neuropathies and sports-related injuries.  A major driver in the mature markets has been the emergence of a younger patient population looking for high-functioning, longer-lasting technologies.

Factors restraininbg the market include: Economic slowdown; ASPs are being slashed to more affordable rates, regulatory impacts (recalls, medical device alerts and surveillance by joint registries in N. America and Europe);  the hip market is mature in the US, W. Europe and Japan; cultural aversion to invasive procedures in most Asian countries and access to trained surgeons.  Government sponsored reimbursement is being scaled back to increase fiscal efficiency. New companies find enormously high entry barriers that include both technology and regulatory hurdles.

Technology trends –  materials (porous/ trabecular, antibiotic infused, more durable plastics like heavily cross-linked or ultra-high molecular weight polyethylene, graphitic surfaces that improve articulation, new combinations like ceramic on metal); designs (modular, gender and race-specific, patient-customized); fixation options now include hybrid implants that have cemented and cement-less components. Robotic surgery is optimizing precision of implantation while MIS devices are facilitating less traumatic surgery.

Leading players include: Zimmer, DePuy, Stryker, Smith and Nephew and Biomet.  Other significant players include Aesculap, and Wright Medical among others.
Niche players with innovative products include Mako Surgical, BioPro Inc., CeramTec, ConfroMIS,  and Corin Group among others.

About Marketstrat, Inc.
Marketstrat assists companies with market, technology, and best practice strategies & intelligence, through a unique combination of published reports, solutions, and services. Our strengths include: a deep understanding of the medical devices value chain, state-of-the-art data collection tools, and robust research methodology.

This research report analyzes the world market for Hip and Knee Reconstruction Devices. The report discusses key players and identifies trends impacting the market for these products. Topics covered include product definitions, strategies, competitive analysis, key market and product segment parameters, market shares, competitive position maps, market conditions, brands, and company profiles.

The report provides detailed market estimates and forecasts for Hip and Knee Reconstruction Devices by product segment, separately for the USA, Canada, LATAM, Germany, France, UK, Italy, Japan, China, India and the Rest of the World (ROW).

Opportunities and Challenges in Advanced Wound Care

Moist Wound Dressings – Opportunities and Challenges in the Advanced Wound Care Market

Even as new opportunities open up in the moist wound dressings market, growth is being stifled by cost-cutting measures in regions with staggering economies.   Clinicians however are faced with the challenge of meeting a rapidly growing demand for advanced wound care products as rates of diabetic ulcers, pressure ulcers and surgical wounds rise.

The World Market for Moist Wound Dressings including foams, semi-permeable/ transparent films, alginates, hydrofibers, hydrogels, hydrocolloids and collagen, was over $4 billion in 2010 growing at a CAGR of 4.5 percent over the next few years. This neew report from Marketstrat predicts that growth rates are likely to increase as regional economies begin to recover.

Key Drivers

Rising incidence of chronic wounds (diabetic wounds, pressure ulcers) and acute wounds (surgical); trend toward preventive healthcare; innovative products, availability of reimbursement for most dressings; demand in emerging healthcare markets.

Key Restraints

High costs compared to traditional dressings, shortage of trained staff and facilities in some regions, reimbursement restrictions, competition with other moist dressings, price competition, and complex regulatory approval process for combination products.

Key Product Segments

Largest segment is foam dressings, largest market is the US; fastest growing market is China.

Key Technologies

Hydrofiber® (carboxymethylcellulose) has been the most significant recent innovation; antimicrobial agents such as Ag ions and PHMB are also important advances.  These products as well as composites target the biggest challenges in wound management, namely exudate management and infection management.

Read More

Interventional Cardiology Market: Boom in Asia Presents New Opportunities and Challenges

The world market for interventional cardiology devices estimated at $9.7 billion presents one of the most dynamic medical device markets growing at a CAGR of 8.7 percent over the next few years.   The market in China is growing the fastest, at a CAGR of 20 to 30 percent in many product segments.  Marketstrat Inc. provides detailed market estimates and forecasts for cardiovascular stents (coronary and carotid), PTCA catheters, atherectomy devices, angiographic catheters and guiding catheters in major geographical markets around the world.

The Interventional Cardiology Devices Markets Worldwide report notes that technology innovations are re-energizing an industry struggling to gain wider acceptance by demonstrating long term safety and efficacy.    New innovations include carotid stents, bio-absorbable coronary DES and revascularization devices for Peripheral Artery Disease (PAD).  Demand for percutaneous intervention (PCI) devices continues to soar with growing patient populations, particularly in emerging markets like China and India.  However, manufacturers have been plagued by intense competition and poor long-term success rates resulting from complications such as distal embolism and delayed stent thrombosis.  Decline in prices is driving down revenues and market shares of leaders; meanwhile small manufacturers have seized the opportunity to capture sizeable share of local and niche markets, e.g. innovators like Spectranetics, CSI and Pathway Medical have been particularly successful in filling in technology gaps with the latest atherectomy devices.

Technological innovation and timely regulatory approval in are the most critical competitive strategies.   Other key factors are favorable comparative clinical studies, clinical training and support, and penetration of emerging healthcare markets which have the highest growth potential.

Read More

Technology Boom in Wound Closure Products Offers New Promise For Reducing Trauma While peeding Up Recovery

The wound closure device market is characterized by a wide range of competing technologies from traditional sutures to the latest tissue adhesives. While trauma wounds as well as surgical wounds require closure, technological advancement is aimed primarily at addressing surgical wound closure. The products aim to reduce infection rates, provide effective hemostasis, provide a microbial barrier and promote faster healing as well as being easier to administer. A general shift toward minimally invasive procedures presents new challenges for wound closure include vascular sealing and tissue closure.

According to Marketstrat Inc., the wound closure market is growing worldwide at a CAGR of almost 6 percent. This market, currently estimated to be just over $6.3 billon is generating new demand due to growing rates of surgical procedures. High growth product segments are hemostats and tissue adhesives/ sealants. Soaring rates of surgical procedures worldwide, in particular vascular procedures and endoscopic procedures are creating demand for easy to-use, biocompatible, fast-acting and more efficacious closure agents. According to the Marketstrat report entitled, ‘Wound Closure Products
Markets Worldwide’, China’s emerging healthcare infrastructure will soon lead to one of the fastest growing markets for wound closure products.

Innovative products have been developed in every wound closure product category. Some of the recently introduced products include:

Hemostats

a) OMNEX™ Surgical Sealant (Ethicon) – vascular reconstructions also has adjunctive hemostatic properties. Ethicon reports that clinical trials indicate a hemostatic rate that is three times faster than oxidized regenerated cellulose.

b) PerClot from CryoLife – is a synthetic absorbable modified polymer (AMP®) for use as a hemostat in surgical procedures or following traumatic injuries.

Sutures

a) The V-loc 90 and 180 knotless wound closure device from Covidien speed up suturing by eliminating the need for knot-tying.

Read More